Halberd (Halberd) Gross-Profit-to-Asset % : 6.90% (As of Jul. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Halberd's annualized Gross Profit for the quarter that ended in Jul. 2023 was $0.00 Mil. Halberd's average Total Assets over the quarter that ended in Jul. 2023 was $0.01 Mil. Therefore, Halberd's annualized Gross-Profit-to-Asset % for the quarter that ended in Jul. 2023 was 6.90%.

Halberd Gross-Profit-to-Asset % Historical Data

The historical data trend for Halberd's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Gross-Profit-to-Asset % Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Gross-Profit-to-Asset %

1.75

4.46

6.90

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Gross-Profit-to-Asset %	1.75	4.46	6.90

Competitive Comparison of Halberd's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Halberd's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Halberd's Gross-Profit-to-Asset % falls into.

Halberd Gross-Profit-to-Asset % Calculation

Halberd's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jul. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jul. 2023 )	/	( (Total Assets (A: Jul. 2022 )	+	Total Assets (A: Jul. 2023 ))	/ count )
	=	0.001	/	( (0.017	+	0.012)	/ 2 )
	=	0.001	/	0.0145
	=	6.90 %

Halberd's annualized Gross-Profit-to-Asset % for the quarter that ended in Jul. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jul. 2023 )	/	( (Total Assets (Q: Jul. 2022 )	+	Total Assets (Q: Jul. 2023 ))	/ count )
	=	0.001	/	( (0.017	+	0.012)	/ 2 )
	=	0.001	/	0.0145
	=	6.90 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Jul. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Halberd Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Halberd's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236